Skip to main content
. 2022 Aug 31;13:987487. doi: 10.3389/fendo.2022.987487

Table 5.

Resistance pattern of gram-negative isolates.

Antibiotic tested   Resistance pattern of isolated Gram-negative bacteria n (%)
Classes Antibiotics Acinetobacter spp(N = 12) Pseudomonas spp(N = 24) K.P(N = 10) E.coli(N = 21) Serratia(N = 6) P. mirabilis (N = 4) P. vulgaris(N = 4) Citrobacter spp(N = 4)
Aminoglycosides AMK 10 (83.3) 11 (45.8) 5 (50 5 (28.8) 2(33.3) 2 (50) 2 (50) 0
TOB 12 (83.3) 21 (87.5) 7 (70) 19 (90.5 5 (83.3) 4 (100) 3 (75) 3 (75)
Tetracycline DO 11 (91.7) 23 (95.8) 10 (100) 18 (86) 6 (100) 4 (100) 3 (75) 3 (75)
Quinolones CPR 8 (66.7) 13 (54.2) 4 (40) 8 (38.0) 5(83.3) 2 (50) 2 (50) 2 (50)
Sulfonamides SXT 10 (83.3) 21 (87.5) 9 (90) 19 (90) 5(83.3) 2 (50) 4 (100) 4 (100)
Chloramphenicol CHL 8 (66.7) 16 (66.7) 3 (30) 2 (9.5) 6(100) 2 (50) 0 2 (100)
Monobactam ATM 7 (58.3) 13 (54.2) 2 (20) 5 (28.8) 2 (33.3) 2 (50) 3 (75) 0
Polymyxin PB 12 (100) 24 (100) 10 (100) 21 (100) 6 (100) 4 (100) 4 (100) 4 (100)
Cephalosporins CXT 11 (91.6) 24 (100) 10 (100) 20 95.2) 6(100) 4(100) 4(50) 4(100)
CFP 12 (100) 24 (100) 10 (100) 21 (100) 6 (100) 4 (100) 4 (100) 4 (100)
CTR 12 (100) 20 (83.3) 6 (60) 11 (52) 6 (100) 3 (75) 1 (25) 2 (50)
CTX 11 (8.3) 21 (87.5) 8 (80) 15 (74) 6 (100) 3 (75) 1 (25) 3 (75)
CAZ 7 (58.3) 13 (54.2) 4 (40) 7 (33.3) 3 (33) 3 (75) 0 0
Beta-lactam Inhibitors TZP 6 (50) 16 (66.7) 4 (40) 7 (33.3) 2(33.3) 2 (50) 0 2 (50)
SAM 12 (100) 24 (100) 10 (100) 21 (100) 6 (100) 4 (100) 4 (100) 4 (100)
AUG 12 (100) 24 (100) 10 (100) 21 (100) 6 (100) 4 (100) 4 (100) 4 (100)
Carbapenem IMI 6 (50) 11 (45.8) 6 (60) 5 (23.8) 4 (66.6) 1 (25) 0 0
MER 7 (58.3) 9 (37.5) 4(40) 6 (28.5) 3 (50) 1(25) 1(25) 0

AMK, Amikacin; TOB, Tobramycin; DO, Doxycycline; CPR, Ciprofloxacin; SXT, Trimethoprim-sulfamethoxazole; FEP, Cefepime; TZP, Piperacillin-Tazobactam; SAM, Ampicillin-Sulbactam; AUG, Augmentin; CTR, Ceftriaxone; CTX, Cefotaxime; CAZ, Ceftazidime; IMI, Imipenem; MER, Meropenem; ATM, Aztreonam.